TNF and systemic lupus erythematosus: Therefore it remains to be determined if indirectly altering TNF-α levels, as hESC-MSCs have done in this study, may be beneficial for SLE patients and/or if the effect on TNFα contributes to the overall hESC-MSC therapeutic effect.